Mohammed Eslam
The University of Sydney · 305 works · 29,337 citations · h-index 59
Top works
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- Reply to: correspondence regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”
- Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
- The changing epidemiology of liver diseases in the Asia–Pacific region
- Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement
- Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
- Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
- ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
- Redefining fatty liver disease: an international patient perspective
- Toward More Accurate Nomenclature for Fatty Liver Diseases
- Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
- Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
- MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach